Effects of Preemptive Single Dose Sustained Release Non-Steroidal Anti-Inflammatory Drugs on Postoperative Complications Following Third Molar Surgery
Abstract
Objective: The aim of this study was to compare the effectiveness of two preemptive sustained-release nonsteroidal antiinflammatory agents in terms of pain, edema and trismus following third molar surgery.
Method: Overall, 30 patients with double-sided vertically positioned impacted third molars were included in this study. The study was randomized and double-blinded. 30 minutes before the surgery, patients were given sustained-release (SR) dexketoprofen trometamol 75 mg and following the surgery the drug administration continued postoperatively for 1 week, once a day. 2 weeks later, the same procedure was applied for the counterside impacted third molar with sustained-release (SR) diclofenac sodium 75 mg. The pain was assessed postoperatively by VAS levels at the 6th, 8th, 12th, 24th and 48th hours and on the 3rd, 5th, and 7th days. Edema and trismus measurements were evaluated on the postoperative 2nd and 7th days.
Result: There was a statistically significant difference between the groups in VAS levels at 6th, 8th, 12th, 24th, and 48th hours, and on the 3rd and 5th days (P <0.01). VAS levels of dexketoprofen trometamol SR group had lower VAS levels than diclofenac sodium SR group. There was no statistically significant difference between the groups in terms of trismus and edema measurement averages on the 2nd and 7th days (P <0.05).
Conclusion: Dexketoprofen trometamol SR and diclofenac sodium SR are similarly effective for the reduction of edema and trismus following impacted third molar surgery; however, dexketoprofen trometamol SR is found to be more efficient in reducing pain.
Keywords
References
- 1. Al-Zoubi H, Alharbi AA, Ferguson DJ, Zafar MS. Frequency of impacted teeth and categorization of impacted canines: a retrospective radiographic study using orthopantomograms. Eur J Dent. 2017;11(1):117-121.
- 2 Farhadi F, Eslami H, Majidi A, Fakhrzadeh V, Ghanizadeh M, KhademNeghad S. Evaluation of adjunctive effect of low-level laser Therapy on pain, swelling and trismus after surgical removal of impacted lower third molar: A double blind randomized clinical trial. Laser Ther. 2017;26(3):181-187.
- 3. Nazir A, Akhtar MU, Ali S. Assessment of different patterns of impacted mandibular third molars and their associated pathologies. J Adv Med Dent Sci Res. 2014;2:14-22.
- 4. O'Hare PE, Wilson BJ, Loga MG, Ariyawardana A. Effect of submucosal dexamethasone injections in the prevention of postoperative pain, trismus, and oedema associated with mandibular third molar surgery: a systematic review and meta-analysis. Int J Oral Maxillofac Surg. 2019;48(11):1456-1469.
- 5. Osunde O, Adebola R, Omeje U. Management of inflammatory complications in third molar surgery: a review of the literature. African health sciences. 2011;11(3):530-37.
- 6. Rodrigues ÉD, Pereira GS, Vasconcelos BC, Ribeiro RC. Effect of preemptive dexamethasone and etoricoxib on postoperative period following impacted third molar surgery-a randomized clinical trial. Med Oral Patol Oral Cir Bucal. 2019;24(6):e746-e751.
- 7. Barbalho JC, Vasconcellos RJ, de Morais HH, Santos LA, Almeida RA, Rêbelo HL. Effects of co-administered dexamethasone and nimesulide on pain, swelling, and trismus following third molar surgery: a randomized, triple-blind, controlled clinical trial. Int J Oral Maxillofac Surg. 2017;46:236-42.
- 8. Barbanoj MJ, Antonijoan RM, Gich I. Clinical pharmacokinetics of dexketoprofen. Clin Pharmacokinet. 2001;40(4):245-62.
Details
Primary Language
English
Subjects
Health Care Administration
Journal Section
Research Article
Authors
Publication Date
March 11, 2021
Submission Date
July 21, 2020
Acceptance Date
November 2, 2020
Published in Issue
Year 2021 Volume: 13 Number: 1


